APO Research
Talk to an analyst

APO RESEARCH · REPORT

Trastuzumab Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Trastuzumab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchTrastuzumab Injection Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Trastuzumab Injection Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Trastuzumab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Trastuzumab Injection Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Trastuzumab Injection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Trastuzumab Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Trastuzumab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Trastuzumab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Trastuzumab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Trastuzumab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Trastuzumab Injection include Celltrion, Glenmark, Samsung Bioepsis, AstraZeneca, Amgen, Shanghai Henlius Biotech, Hisun Biopharmaceutical, Pfizer and Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Trastuzumab Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Trastuzumab Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Trastuzumab Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Trastuzumab Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Trastuzumab Injection Segment by Company

Celltrion

Glenmark

Samsung Bioepsis

AstraZeneca

Amgen

Shanghai Henlius Biotech

Hisun Biopharmaceutical

Pfizer

Roche

Mylan

Remegen Co., Ltd.

Trastuzumab Injection Segment by Type

60 mg

440 mg

150 mg

Others

Trastuzumab Injection Segment by Application

Hospitals

Clinics

Others

Trastuzumab Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Trastuzumab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Trastuzumab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Trastuzumab Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Trastuzumab Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Trastuzumab Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Trastuzumab Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Trastuzumab Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Trastuzumab Injection Industry Trends Table 2. Trastuzumab Injection Industry Drivers Table 3. Trastuzumab Injection Industry Opportunities and Challenges Table 4. Trastuzumab Injection Industry Restraints Table 5. Global Trastuzumab Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Trastuzumab Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Trastuzumab Injection Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Trastuzumab Injection Sales Market Share by Manufacturers Table 9. Global Trastuzumab Injection Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Trastuzumab Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Trastuzumab Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Trastuzumab Injection Manufacturers, Product Type & Application Table 13. Global Trastuzumab Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Trastuzumab Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 60 mg Table 17. Major Manufacturers of 440 mg Table 18. Major Manufacturers of 150 mg Table 19. Major Manufacturers of Others Table 20. Global Trastuzumab Injection Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Trastuzumab Injection Sales by Type (2021-2026) & (k units) Table 22. Global Trastuzumab Injection Sales by Type (2027-2032) & (k units) Table 23. Global Trastuzumab Injection Sales Market Share by Type (2021-2026) Table 24. Global Trastuzumab Injection Sales Market Share by Type (2027-2032) Table 25. Global Trastuzumab Injection Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Trastuzumab Injection Revenue by Type (2021-2026) & (k units) Table 27. Global Trastuzumab Injection Revenue by Type (2027-2032) & (k units) Table 28. Global Trastuzumab Injection Revenue Market Share by Type (2021-2026) Table 29. Global Trastuzumab Injection Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospitals Table 31. Major Manufacturers of Clinics Table 32. Major Manufacturers of Others Table 33. Global Trastuzumab Injection Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Trastuzumab Injection Sales by Application (2021-2026) & (k units) Table 35. Global Trastuzumab Injection Sales by Application (2027-2032) & (k units) Table 36. Global Trastuzumab Injection Sales Market Share by Application (2021-2026) Table 37. Global Trastuzumab Injection Sales Market Share by Application (2027-2032) Table 38. Global Trastuzumab Injection Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Trastuzumab Injection Revenue by Application (2021-2026) & (k units) Table 40. Global Trastuzumab Injection Revenue by Application (2027-2032) & (k units) Table 41. Global Trastuzumab Injection Revenue Market Share by Application (2021-2026) Table 42. Global Trastuzumab Injection Revenue Market Share by Application (2027-2032) Table 43. Global Trastuzumab Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Trastuzumab Injection Sales by Region (2021-2026) & (k units) Table 45. Global Trastuzumab Injection Sales Market Share by Region (2021-2026) Table 46. Global Trastuzumab Injection Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Trastuzumab Injection Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Trastuzumab Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Trastuzumab Injection Sales by Country (2021-2026) & (k units) Table 50. North America Trastuzumab Injection Sales by Country (2027-2032) & (k units) Table 51. Europe Trastuzumab Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Trastuzumab Injection Sales by Country (2021-2026) & (k units) Table 53. Europe Trastuzumab Injection Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Trastuzumab Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Trastuzumab Injection Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Trastuzumab Injection Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Trastuzumab Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Trastuzumab Injection Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Trastuzumab Injection Sales by Country (2027-2032) & (k units) Table 60. Global Trastuzumab Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Trastuzumab Injection Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Trastuzumab Injection Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Trastuzumab Injection Revenue Market Share by Region (2021-2026) Table 64. Global Trastuzumab Injection Revenue Market Share by Region (2027-2032) Table 65. Celltrion Company Information Table 66. Celltrion Business Overview Table 67. Celltrion Trastuzumab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Celltrion Trastuzumab Injection Product Portfolio Table 69. Celltrion Recent Development Table 70. Glenmark Company Information Table 71. Glenmark Business Overview Table 72. Glenmark Trastuzumab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Glenmark Trastuzumab Injection Product Portfolio Table 74. Glenmark Recent Development Table 75. Samsung Bioepsis Company Information Table 76. Samsung Bioepsis Business Overview Table 77. Samsung Bioepsis Trastuzumab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Samsung Bioepsis Trastuzumab Injection Product Portfolio Table 79. Samsung Bioepsis Recent Development Table 80. AstraZeneca Company Information Table 81. AstraZeneca Business Overview Table 82. AstraZeneca Trastuzumab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. AstraZeneca Trastuzumab Injection Product Portfolio Table 84. AstraZeneca Recent Development Table 85. Amgen Company Information Table 86. Amgen Business Overview Table 87. Amgen Trastuzumab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Amgen Trastuzumab Injection Product Portfolio Table 89. Amgen Recent Development Table 90. Shanghai Henlius Biotech Company Information Table 91. Shanghai Henlius Biotech Business Overview Table 92. Shanghai Henlius Biotech Trastuzumab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Shanghai Henlius Biotech Trastuzumab Injection Product Portfolio Table 94. Shanghai Henlius Biotech Recent Development Table 95. Hisun Biopharmaceutical Company Information Table 96. Hisun Biopharmaceutical Business Overview Table 97. Hisun Biopharmaceutical Trastuzumab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Hisun Biopharmaceutical Trastuzumab Injection Product Portfolio Table 99. Hisun Biopharmaceutical Recent Development Table 100. Pfizer Company Information Table 101. Pfizer Business Overview Table 102. Pfizer Trastuzumab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Pfizer Trastuzumab Injection Product Portfolio Table 104. Pfizer Recent Development Table 105. Roche Company Information Table 106. Roche Business Overview Table 107. Roche Trastuzumab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Roche Trastuzumab Injection Product Portfolio Table 109. Roche Recent Development Table 110. Mylan Company Information Table 111. Mylan Business Overview Table 112. Mylan Trastuzumab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Mylan Trastuzumab Injection Product Portfolio Table 114. Mylan Recent Development Table 115. Remegen Co., Ltd. Company Information Table 116. Remegen Co., Ltd. Business Overview Table 117. Remegen Co., Ltd. Trastuzumab Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Remegen Co., Ltd. Trastuzumab Injection Product Portfolio Table 119. Remegen Co., Ltd. Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Trastuzumab Injection Distributors List Table 123. Trastuzumab Injection Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Trastuzumab Injection Product Image Figure 2. Global Trastuzumab Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Trastuzumab Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Trastuzumab Injection Sales (2021-2032) & (k units) Figure 5. Global Trastuzumab Injection Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Trastuzumab Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 60 mg Image Figure 9. 440 mg Image Figure 10. 150 mg Image Figure 11. Others Image Figure 12. Global Trastuzumab Injection Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Trastuzumab Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Trastuzumab Injection Sales Market Share by Type (2021-2032) Figure 15. Global Trastuzumab Injection Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Trastuzumab Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Trastuzumab Injection Revenue Market Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Clinics Image Figure 20. Others Image Figure 21. Global Trastuzumab Injection Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Trastuzumab Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Trastuzumab Injection Sales Market Share by Application (2021-2032) Figure 24. Global Trastuzumab Injection Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Trastuzumab Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Trastuzumab Injection Revenue Market Share by Application (2021-2032) Figure 27. North America Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Trastuzumab Injection Sales Market Share by Country (2021-2032) Figure 29. U.S. Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Trastuzumab Injection Sales Market Share by Country (2021-2032) Figure 34. Germany Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Trastuzumab Injection Sales Market Share by Country (2021-2032) Figure 41. China Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Trastuzumab Injection Sales Market Share by Country (2021-2032) Figure 49. Brazil Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Trastuzumab Injection Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Trastuzumab Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Trastuzumab Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Trastuzumab Injection Revenue (2021-2032) & (US$ Million) Figure 60. North America Trastuzumab Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Trastuzumab Injection Revenue (2021-2032) & (US$ Million) Figure 62. Europe Trastuzumab Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Trastuzumab Injection Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Trastuzumab Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Trastuzumab Injection Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Trastuzumab Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Trastuzumab Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Trastuzumab Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 60 mg
  • 440 mg
  • 150 mg
  • Others
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Celltrion
  • Glenmark
  • Samsung Bioepsis
  • AstraZeneca
  • Amgen
  • Shanghai Henlius Biotech
  • Hisun Biopharmaceutical
  • Pfizer
  • Roche
  • Mylan
  • Remegen Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Trastuzumab Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Trastuzumab Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Trastuzumab Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Trastuzumab Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Trastuzumab Injection Market Dynamics
  1. 2.1 Trastuzumab Injection Industry Trends
  2. 2.2 Trastuzumab Injection Industry Drivers
  3. 2.3 Trastuzumab Injection Industry Opportunities and Challenges
  4. 2.4 Trastuzumab Injection Industry Restraints
3 Trastuzumab Injection Market by Manufacturers
  1. 3.1 Global Trastuzumab Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Trastuzumab Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Trastuzumab Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Trastuzumab Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Trastuzumab Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Trastuzumab Injection Manufacturers, Product Type & Application
  7. 3.7 Global Trastuzumab Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Trastuzumab Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Trastuzumab Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Trastuzumab Injection Tier 1, Tier 2, and Tier 3
4 Trastuzumab Injection Market by Type
  1. 4.1 Trastuzumab Injection Type Introduction
  2. 4.1.1 60 mg
  3. 4.1.2 440 mg
  4. 4.1.3 150 mg
  5. 4.1.4 Others
  6. 4.2 Global Trastuzumab Injection Sales by Type
  7. 4.2.1 Global Trastuzumab Injection Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Trastuzumab Injection Sales by Type (2021-2032)
  9. 4.2.3 Global Trastuzumab Injection Sales Market Share by Type (2021-2032)
  10. 4.3 Global Trastuzumab Injection Revenue by Type
  11. 4.3.1 Global Trastuzumab Injection Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Trastuzumab Injection Revenue by Type (2021-2032)
  13. 4.3.3 Global Trastuzumab Injection Revenue Market Share by Type (2021-2032)
5 Trastuzumab Injection Market by Application
  1. 5.1 Trastuzumab Injection Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Trastuzumab Injection Sales by Application
  6. 5.2.1 Global Trastuzumab Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Trastuzumab Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Trastuzumab Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Trastuzumab Injection Revenue by Application
  10. 5.3.1 Global Trastuzumab Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Trastuzumab Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Trastuzumab Injection Revenue Market Share by Application (2021-2032)
6 Global Trastuzumab Injection Sales by Region
  1. 6.1 Global Trastuzumab Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Trastuzumab Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Trastuzumab Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Trastuzumab Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Trastuzumab Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Trastuzumab Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Trastuzumab Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Trastuzumab Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Trastuzumab Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Trastuzumab Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Trastuzumab Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Trastuzumab Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Trastuzumab Injection Revenue by Region
  1. 7.1 Global Trastuzumab Injection Revenue by Region
  2. 7.1.1 Global Trastuzumab Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Trastuzumab Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Trastuzumab Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Trastuzumab Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Trastuzumab Injection Revenue (2021-2032)
  8. 7.2.2 North America Trastuzumab Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Trastuzumab Injection Revenue (2021-2032)
  11. 7.3.2 Europe Trastuzumab Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Trastuzumab Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Trastuzumab Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Trastuzumab Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Trastuzumab Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Celltrion
  2. 8.1.1 Celltrion Company Information
  3. 8.1.2 Celltrion Business Overview
  4. 8.1.3 Celltrion Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Celltrion Trastuzumab Injection Product Portfolio
  6. 8.1.5 Celltrion Recent Developments
  7. 8.2 Glenmark
  8. 8.2.1 Glenmark Company Information
  9. 8.2.2 Glenmark Business Overview
  10. 8.2.3 Glenmark Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Glenmark Trastuzumab Injection Product Portfolio
  12. 8.2.5 Glenmark Recent Developments
  13. 8.3 Samsung Bioepsis
  14. 8.3.1 Samsung Bioepsis Company Information
  15. 8.3.2 Samsung Bioepsis Business Overview
  16. 8.3.3 Samsung Bioepsis Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Samsung Bioepsis Trastuzumab Injection Product Portfolio
  18. 8.3.5 Samsung Bioepsis Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Trastuzumab Injection Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
  25. 8.5 Amgen
  26. 8.5.1 Amgen Company Information
  27. 8.5.2 Amgen Business Overview
  28. 8.5.3 Amgen Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Amgen Trastuzumab Injection Product Portfolio
  30. 8.5.5 Amgen Recent Developments
  31. 8.6 Shanghai Henlius Biotech
  32. 8.6.1 Shanghai Henlius Biotech Company Information
  33. 8.6.2 Shanghai Henlius Biotech Business Overview
  34. 8.6.3 Shanghai Henlius Biotech Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Henlius Biotech Trastuzumab Injection Product Portfolio
  36. 8.6.5 Shanghai Henlius Biotech Recent Developments
  37. 8.7 Hisun Biopharmaceutical
  38. 8.7.1 Hisun Biopharmaceutical Company Information
  39. 8.7.2 Hisun Biopharmaceutical Business Overview
  40. 8.7.3 Hisun Biopharmaceutical Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hisun Biopharmaceutical Trastuzumab Injection Product Portfolio
  42. 8.7.5 Hisun Biopharmaceutical Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Trastuzumab Injection Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 Roche
  50. 8.9.1 Roche Company Information
  51. 8.9.2 Roche Business Overview
  52. 8.9.3 Roche Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Roche Trastuzumab Injection Product Portfolio
  54. 8.9.5 Roche Recent Developments
  55. 8.10 Mylan
  56. 8.10.1 Mylan Company Information
  57. 8.10.2 Mylan Business Overview
  58. 8.10.3 Mylan Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mylan Trastuzumab Injection Product Portfolio
  60. 8.10.5 Mylan Recent Developments
  61. 8.11 Remegen Co., Ltd.
  62. 8.11.1 Remegen Co., Ltd. Company Information
  63. 8.11.2 Remegen Co., Ltd. Business Overview
  64. 8.11.3 Remegen Co., Ltd. Trastuzumab Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Remegen Co., Ltd. Trastuzumab Injection Product Portfolio
  66. 8.11.5 Remegen Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Trastuzumab Injection Value Chain Analysis
  2. 9.1.1 Trastuzumab Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Trastuzumab Injection Production Mode & Process
  6. 9.2 Trastuzumab Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Trastuzumab Injection Distributors
  9. 9.2.3 Trastuzumab Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst